Added to YB: 2023-09-15
Pitch date: 2023-09-15
GRPH [bullish]
Graphite Bio, Inc.
+37.07%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of March 21, 2024, Graphite Bio, Inc. was acquired by LENZ Therapeutics, Inc., in a reverse merger transaction.
Market Cap
$185.2M
Pitch Price
$10.98
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.02
P/E
-1.45
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Graphite Bio: Broken Biotech, New CEO, Operating Lease Questions
A summary for this pitch has not been created yet.
Read full article (1 min)